Published June 30, 2022 | Version https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue6,Article73.pdf

Comparison of Efficacy of Ibuprofen & Paracetamol in the Treatment of Acute Migraine in Children – A Randomized Controlled Clinical

  • 1. Assistant professor, Department of Pediatrics, JNUIMSRC, Jaipur
  • 2. Associate professor, Department of Pediatrics, JNUIMSRC, Jaipur

Description

Background: Migraine is a common clinical condition in children affecting their quality of life. Limited literature studies are available on the pharmacological treatment of acute migraine in children. Thus, the present randomized controlled clinical blind trial was designed to evaluate the clinical efficacy of oral Ibuprofen with oral paracetamol in the acute treatment of migraine in children. Material & Method: The study included 60 school going children (age 6-10yrs) fulfilling criteria of International Classification for headache disorders,3rd edition, with at least one migraine attacks per month for 2 hours; with recurrence for at least 6 months & with unsatisfactory relief from prior treatments. Written informed consent acquired from parents & permission undertaken by the ethical committee. Any other etiology of migraine attacks was ruled out. The cases were randomized into Group Ibuprofen (n=30) and Group Paracetamol (n=30). A written record was maintained at home. Pain relief (≥ 2-point reduction from the baseline values) & freedom from pain (VAS scale), associated symptoms, side effects of drugs were noted. Results: No statistical differences in baseline characteristics found in the two groups. Pain relief in 95% of children and 33.3% reached freedom from pain at 2 hr interval with relief in associated symptoms in 50% of children. Relief after drug administration noted with regards to associated symptoms of nausea, vomiting, photophobia & phonophobia were observed with no statistically significant differences in both groups. Mild adverse events of epigastic pain & nausea reported in both groups. Conclusion: Both Ibuprofen & Paracetamol are equally efficacious and can be adopted as safe, economical drugs in relieving the acute migraine in children.

 

 

 

Abstract (English)

Background: Migraine is a common clinical condition in children affecting their quality of life. Limited literature studies are available on the pharmacological treatment of acute migraine in children. Thus, the present randomized controlled clinical blind trial was designed to evaluate the clinical efficacy of oral Ibuprofen with oral paracetamol in the acute treatment of migraine in children. Material & Method: The study included 60 school going children (age 6-10yrs) fulfilling criteria of International Classification for headache disorders,3rd edition, with at least one migraine attacks per month for 2 hours; with recurrence for at least 6 months & with unsatisfactory relief from prior treatments. Written informed consent acquired from parents & permission undertaken by the ethical committee. Any other etiology of migraine attacks was ruled out. The cases were randomized into Group Ibuprofen (n=30) and Group Paracetamol (n=30). A written record was maintained at home. Pain relief (≥ 2-point reduction from the baseline values) & freedom from pain (VAS scale), associated symptoms, side effects of drugs were noted. Results: No statistical differences in baseline characteristics found in the two groups. Pain relief in 95% of children and 33.3% reached freedom from pain at 2 hr interval with relief in associated symptoms in 50% of children. Relief after drug administration noted with regards to associated symptoms of nausea, vomiting, photophobia & phonophobia were observed with no statistically significant differences in both groups. Mild adverse events of epigastic pain & nausea reported in both groups. Conclusion: Both Ibuprofen & Paracetamol are equally efficacious and can be adopted as safe, economical drugs in relieving the acute migraine in children.

 

 

 

Files

IJPCR,Vol14,Issue6,Article73.pdf

Files (141.1 kB)

Name Size Download all
md5:58fa0148fb516fa0ce8d860ce769df54
141.1 kB Preview Download

Additional details

Dates

Accepted
2022-06-05

References

  • 1. Greene K, Irwin SL, Gelfand AA. Pediatric migraine an update.Neurol Clin. 2019; 37: 815–33. 2. Wilson JF. In the clinic. Migraine [published correction appears in Ann Intern Med. 2008;148(5):408]. Ann Intern Med. 2007;147(9): ITC11-1– ITC11-16. 3. Suthisisang C, Poolsup N, Kittikulsuth W, Pudchakan P, Wiwatpanich P. Efficacy of low-dose ibuprofen in acute migraine treatment: systematic review and meta-analysis. Ann Pharmacother. 2007;41(11):1782- 1791. 4. Meredith JT, Wait S, Brewer KL. A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med. 2003;21(3):173-175. 5. Morey SS. Guidelines on migraine: part 2. General principles of drug therapy. Am Fam Physician. 2000;62(8):1915-1917. 6. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5- HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358(9294):1668-1675. 7. Goldstein J, Silberstein SD, Saper JR, Ryan RE Jr, Lipton RB. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallelgroup, single-dose, placebo-controlled study. Headache. 2006;46(3):444-453. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs. 2000;60(6):1259-1287. 8. Dib M, Massiou H, Weber M, Henry P, Garcia-Acosta S, Bousser MG; BiProfenid Migraine Study Group. Efficacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial. Neurology. 2002;58(11):1660-1665. 9. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63(12):2215-2224. 10. Gilmore B, Michael M, Treatment of Acute Migraine Headache .Am Fam Physician. 2011;83(3):271-280. 11. Lewis DW, Winner P, Hershey AD, Wasiewski WW; Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007;120(2):390- 396. 12. Pavithra V, Mishra D, Behera S, Juneja M. Paracetamol versus ibuprofen for the acute treatment of migraine headache in children: a blinded randomized controlled trial. Indian J Pediatr. 2020. 13. S. Evers, A. Rahmann, C. Kraemer et al., "Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen," Neurology, vol. 67, no. 3, pp. 497–499, 2006. 14. Ibuprofen or Acetaminophen for the Acute Treatment of Migraine in Children: A Double-blind, Randomized, Placebo-controlled, Crossover Study Mirja L. Hamalainen, Kalle Hoppu, Esko Valkeila, et al. Neurology 1997;48;103-107 15. A. L. Drendel, M. H. Gorelick, S. J. Weisman, R. Lyon, D. C.Brousseau, and M. K. Kim, "A randomized clinical trial of ibuprofen versusacetaminophen with codeine for acute pediatric arm fracture pain," Annals of Emergency Medicine, vol. 54,no. 4, pp. 553–560, 2009. 16. E. Clark, A. C. Plint, R. Correll, I. Gaboury, and B. Passi, "A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma," Pediatrics, vol. 119, no. 3, pp. 460–467, 2007. 17. N. Poonai, G. Bhullar, K. Lin et al., "Oral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trial," CMAJ, vol. 186, no. 18, pp. 1358–1363, 2014. 18. L Damen1 , J Bruijn2,4, BW Koes1 , MY Berger1 , J Passchier3 & AP Verhagen1 Prophylactic treatment of migraine in children. Part 1. A systematic review of nonpharmacological trials .Cephalalgia, 2005, 26, 373–383 19. E. N. De Vries, M. A. Ramrattan, S. M. Smorenburg, D. J.Gouma, and M. A. Boermeester, "The incidence and nature of in-hospital adverse events: a systematic review," Quality &Safety in Health Care, vol. 17, no. 3, pp. 216– 223, 2008. 20. A. L. Drendel, M. H. Gorelick, S. J. Weisman, R. Lyon, D. C.Brousseau, and M. K. Kim, "A randomized clinical trial of ibuprofen versus acetaminophen with codeine for acute pediatric arm fracture pain," Annals of Emergency Medicine, vol. 54,no. 4, pp. 553–560, 2009. 21. Giovanni Prezioso , Agnese Suppiej , Valentina Alberghini , Patrizia Bergonzini , Maria Elena Capra ,Ilaria Corsini et al Pediatric Headache in Primary Care and Emergency Departments: Consensus with RAND/UCLA Method. Life 2022, 12, 142-193 22. Hartling L, Ali S, Dryden DM, et al. How Safe Are Common Analgesics for the Treatment of Acute Pain for Children? A Systematic Review. Pain Res Manag. 2016; 2016:5346819. 23. S. M. Lesko and A. A. Mitchell, "The safety of acetaminophen and ibuprofen among children younger than two years old," Pediatrics, vol. 104, no. 4, article e39, 1999. 24. D. A. Perrott, T. Piira, B. Goodenough, and G. D. Champion, Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: a meta-analysis, Archives of Pediatricsand Adolescent Medicine, 2004:158(6): 521–526.